Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2003

01-05-2003 | Case Report

Rapid Improvement of Disseminated Intravascular Coagulation by Donor Leukocyte Infusions in a Patient with Promyelocytic Crisis of Chronic Myelogenous Leukemia after Reduced-Intensity Stem Cell Transplantation from an HLA 2-Antigen—Mismatched Mother

Authors: Kosei Matsue, Konagi Yamada, Masami Takeuchi, Takayuki Tabayashi

Published in: International Journal of Hematology | Issue 4/2003

Login to get access
Metadata
Title
Rapid Improvement of Disseminated Intravascular Coagulation by Donor Leukocyte Infusions in a Patient with Promyelocytic Crisis of Chronic Myelogenous Leukemia after Reduced-Intensity Stem Cell Transplantation from an HLA 2-Antigen—Mismatched Mother
Authors
Kosei Matsue
Konagi Yamada
Masami Takeuchi
Takayuki Tabayashi
Publication date
01-05-2003
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2003
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02982653

Other articles of this Issue 4/2003

International Journal of Hematology 4/2003 Go to the issue

OriginalPaper

The Pathogenetic Role of Oncogenes Deregulated by Chromosomal Translocation in B-Cell Malignancies

Case Report

Sweet’s Syndrome Associated with Recurrent Fever in a Patient with Trisomy 8 Myelodysplastic Syndrome

OriginalPaper

The Molecular Basis for the Generation of Hodgkin and Reed-Sternberg Cells in Hodgkin’s Lymphoma

OriginalPaper

Seroindeterminate HTLV-1 Prevalence and Characteristics in Blood Donors in Taiwan

Case Report

Persistent Remission after Immunosuppressive Therapy of Hairy Cell Leukemia Mimicking Aplastic Anemia: Two Case Reports

OriginalPaper

Expression of Apoptosis-Associated Protein RCAS1 in Macrophages of Histiocytic Necrotizing Lymphadenitis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits